Comparison and exploration of the prognostic value of the advanced lung cancer inflammation index, prognostic nutritional index, and systemic immune-inflammation index in newly diagnosed diffuse large B-cell lymphoma
نویسندگان
چکیده
Comparison and exploration of the prognostic value advanced lung cancer inflammation index, nutritional systemic immune-inflammation index in newly diagnosed diffuse large B-cell lymphoma
منابع مشابه
Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study
The International Prognostic Index (IPI) is a widely accepted model that is used to predict the prognosis of patients with diffuse large B-cell lymphoma (DLBCL) who are treated using chemotherapy. However, the prognostic value of the IPI has been a focal point of debate in the immunochemotherapy era. The aim of this study was to reassess the value of the IPI and revised IPI (R-IPI) in a Chinese...
متن کاملInflammation-based prognostic scores and nutritional prognostic index in patients with locally-advanced unresectable colorectal cancer
BACKGROUND Unresectable colorectal cancer has a poor prognosis. However, some patients survive intensive chemotherapy, and complete resection of primary and metastatic tumors may even be possible. In the present study, we examined the prognostic factors associated with survival after intensive chemotherapy in patients with unresectable colorectal cancer. METHODS This retrospective study enrol...
متن کاملPrognostic value of systemic immune-inflammation index in patients with gastric cancer
BACKGROUND Inflammation-based indexes have been used to predict survival and recurrence in cancer patients. Systemic immune-inflammation index (SII) was reported to be associated with prognosis in some malignant tumors. In the present study, we aimed to explore the association between SII and the prognosis of patients with gastric cancer. METHODS We retrospectively analyzed data from 444 gast...
متن کاملThe Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
The International Prognostic Index (IPI; age, the disease stage according to the Ann Arbor system, serum lactate dehydrogenase (LDH), Eastern Cooperative Oncology Group (ECOG) performance status (PS) and the presence of extranodal involvement (ENI)) has been the traditionally utilized prognostic tool for diffuse large B-cell lymphoma (DLBCL) treated with cyclophosphamide, doxorubicin, vincristi...
متن کاملEnhanced international prognostic index in Japanese patients with diffuse large B-cell lymphoma
To evaluate the National Comprehensive Cancer Network (NCCN) International Prognostic Index (IPI), we analyzed 284 patients treated with the combination of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in our institution in Japan. Their 5-year overall survival (OS) by risk level was 80.7%, 74.8%, 55.4% and 67.5% (P=0.005); and their 5-year progression-free survi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of palliative medicine
سال: 2021
ISSN: ['2224-5839', '2224-5820']
DOI: https://doi.org/10.21037/apm-21-2067